Harald Holte

24PUBLICATIONS
112CO-AUTHORS
Haematological tumoursPredictive and prognostic markersApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Cancer therapy (excl. chemotherapy and radiation therapy)Liquid biopsies
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (24)

|Aug 25, 2026
Impact of Intensified Chemoimmunotherapy Regimens in Aggressive Non-Hodgkin Lymphoma on Reproduction Patterns.

|Apr 22, 2026
A targeted circulating tumor DNA landscape of copy number aberrations in large B-cell lymphomas.

|Nov 18, 2025
Five-Year Analysis of the JULIET Trial of Tisagenlecleucel in Patients With Relapsed/Refractory Large B-Cell Lymphoma.

Richard T Maziarz, Michael R Bishop, Constantine S Tam

|Sep 08, 2025
Fixed-duration epcoritamab plus R2 drives favorable outcomes in relapsed or refractory follicular lymphoma.

Lorenzo Falchi, Anna Sureda, Sirpa Leppä

|Jul 17, 2025
High-grade B-cell lymphoma, not otherwise specified: an LLMPP study.

Brett Collinge, Laura K Hilton, Jasper Wong

|May 13, 2025
Biomarker-adapted treatment in high-risk large B-cell lymphoma.

Sirpa Leppä, Leo Meriranta, Maare Arffman

Pageof 4

Frequent Collaborators

5 joint publications

Sirpa Leppä

4 joint publications

Ingrid Glimelius

3 joint publications

Lisa Rimsza

3 joint publications

Joshua P Entrop